PMC9857283_01
T2 weighted fluid-attenuated inversion recovery magnetic resonance images demonstrating (A) periventricular lesion and (B) lesion in cervical spinal cord consistent with multiple sclerosis.
ac9-10-e00955-g001.jpg
PMC9857283_01_ac9-10-e00955-g001.jpg
F1
She was diagnosed with relapsing MS after 2 relapses that same year, and magnetic resonance imaging features were consistent with MS (Figure 1).
Endoscopic image before initiation of ozanimod showing active disease with complete loss of vascular pattern, mild mucosal bleeding, and erosions with exudates.
ac9-10-e00955-g002.jpg
PMC9857283_01_ac9-10-e00955-g002.jpg
F2
Colonoscopy showed features of active disease with a modified Mayo endoscopic score of 2 diffusely involving colonic mucosa extending between the rectum and hepatic flexure of the colon (Figure 2).
Endoscopic image 6 months after the initiation of ozanimod showing normal mucosa suggestive of endoscopic remission.
ac9-10-e00955-g003.jpg
PMC9857283_01_ac9-10-e00955-g003.jpg
F3
On repeat evaluation 6 months after the initiation of ozanimod, she was in clinical and endoscopic remission (modified Mayo endoscopic score 0) and her MS also remains stable (Figures 3).